Time and cost-analysis of virtual surgical planning for head and neck reconstruction: A matched pair analysis.


Journal

Oral oncology
ISSN: 1879-0593
Titre abrégé: Oral Oncol
Pays: England
ID NLM: 9709118

Informations de publication

Date de publication:
01 2020
Historique:
received: 01 05 2019
revised: 21 09 2019
accepted: 23 11 2019
pubmed: 4 12 2019
medline: 21 10 2020
entrez: 4 12 2019
Statut: ppublish

Résumé

Virtual surgical planning (VSP) uses patient-specific modelling of the facial skeleton to provide a tailored surgical plan which may increase accuracy and reduce operating time. The aim of this study was to perform a time and cost-analysis comparing patients treated with and without VSP-technology. A retrospective analysis of 138 patients undergoing microvascular free flap mandible (76.8%) or maxillary (23.2%) reconstruction between 2010 and 2018 was performed. The cohort was divided into two groups according to reconstruction-approach: non-VSP and proprietary-VSP (P-VSP). Cost-analysis was performed comparing non-VSP and P-VSP by matching patients according to site, bone flap, indication, complexity and age. Fibula, scapula and iliac crest free flaps were used in 92 patients (66.7%), 33 patients (23.9%) and 13 patients (9.4%), respectively. Eight patients (5.8%) required revision of the microvascular anastomosis, of which four flaps were salvaged giving a 2.9% flap failure rate. P-VSP was associated with shorter median length of stay (LOS) (10.0 vs 13.0 days, p = 0.009), lower mean procedure time (507.38 vs 561.75 min, p = 0.042), and similar median total cost ($34939.00 vs $34653.00, p = 0.938), despite higher complexity (2.0 vs 1.0, p = 0.09). In the matched-series, P-VSP was associated with a similar median LOS (10.5 vs 11 days), lower mean procedure time (497 vs 555 min, p = 0.231), lower mean total cost ($35,493 v $37,345) but higher median total cost ($35504.50 vs $32391.50, p = 0.607), although not statistically different. VSP-technology represents a helpful surgical tool for complex reconstructions, without adversely impacting on the overall-cost of treatment.

Identifiants

pubmed: 31794886
pii: S1368-8375(19)30402-6
doi: 10.1016/j.oraloncology.2019.104491
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104491

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Francesco Mazzola (F)

Sydney Head and Neck Cancer Institute, Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, Australia; IRCCS Ospedale Policlinico San Martino, Genova, Italy; Department of Otorhinolaryngology-Head and Neck Surgery, University of Genoa, Genova, Italy. Electronic address: mazzola.fra@gmail.com.

Fiona Smithers (F)

Sydney Head and Neck Cancer Institute, Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, Australia; Department of Plastic, Burns and Maxillofacial Surgery, Hutt Valley Hospital, Lower Hutt, New Zealand.

Kai Cheng (K)

Institute of Academic Surgery at Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia.

Payal Mukherjee (P)

Institute of Academic Surgery at Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia.

Tsu-Hui Hubert Low (TH)

Sydney Head and Neck Cancer Institute, Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, Australia; Institute of Academic Surgery at Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia.

Sydney Ch'ng (S)

Sydney Head and Neck Cancer Institute, Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, Australia; Institute of Academic Surgery at Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; Department of Plastic Surgery, Royal Prince Alfred Hospital, Sydney, Australia.

Carsten E Palme (CE)

Sydney Head and Neck Cancer Institute, Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia.

Jonathan R Clark (JR)

Sydney Head and Neck Cancer Institute, Department of Head and Neck Surgery, Chris O'Brien Lifehouse, Sydney, Australia; Institute of Academic Surgery at Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia; Central Clinical School, University of Sydney, Sydney, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH